Inovio Pharmaceuticals Inc vs Macy's Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Macy's Inc trades at $23.78 (market cap $6.13B). The key difference: Macy's Inc is far larger — about 68.7× Inovio Pharmaceuticals Inc's market cap, and Macy's Inc pays a 3.29% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | M | |
|---|---|---|
Market Cap | $89.27M | $6.13B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $25.96 |
52-Week Low | $1.05 | $11.90 |
Enterprise Value | $60.28M | $9.95B |
Dividend Yield | — | 3.29% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →